[
  {
    "ts": null,
    "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=8c533d23108f8191704cce4f9ea0b123ba12dff0e4377337875ff9e1a38f70fb",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745512980,
      "headline": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "id": 134077223,
      "image": "",
      "related": "REGN",
      "source": "MarketWatch",
      "summary": "Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=8c533d23108f8191704cce4f9ea0b123ba12dff0e4377337875ff9e1a38f70fb"
    }
  },
  {
    "ts": null,
    "headline": "Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release",
    "summary": "Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=449f0c9b98b8d0760fed5c6a7c93e67693b0a7c2fe2fb263a0c27cb067a5617d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745503294,
      "headline": "Exact Sciences (EXAS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release",
      "id": 134067968,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Exact Sciences (EXAS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=449f0c9b98b8d0760fed5c6a7c93e67693b0a7c2fe2fb263a0c27cb067a5617d"
    }
  },
  {
    "ts": null,
    "headline": "What Analyst Projections for Key Metrics Reveal About Regeneron (REGN) Q1 Earnings",
    "summary": "Besides Wall Street's top -and-bottom-line estimates for Regeneron (REGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.",
    "url": "https://finnhub.io/api/news?id=6fc789c495e56f5787191fe98c40a920b617f88062aefa0cc054405a22e55831",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745500518,
      "headline": "What Analyst Projections for Key Metrics Reveal About Regeneron (REGN) Q1 Earnings",
      "id": 134067969,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "Besides Wall Street's top -and-bottom-line estimates for Regeneron (REGN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.",
      "url": "https://finnhub.io/api/news?id=6fc789c495e56f5787191fe98c40a920b617f88062aefa0cc054405a22e55831"
    }
  }
]